TransMedics Group, Inc.
TMDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,071,891 | $2,566,596 | $1,824,235 | $529,139 |
| - Cash | $336,650 | $394,812 | $201,182 | $25,580 |
| + Debt | $518,287 | $515,946 | $67,555 | $43,801 |
| Enterprise Value | $2,253,528 | $2,687,730 | $1,690,608 | $547,360 |
| Revenue | $441,540 | $241,623 | $93,459 | $30,262 |
| % Growth | 82.7% | 158.5% | 208.8% | – |
| Gross Profit | $262,081 | $154,093 | $65,272 | $21,159 |
| % Margin | 59.4% | 63.8% | 69.8% | 69.9% |
| EBITDA | $69,947 | -$7,703 | -$28,961 | -$38,488 |
| % Margin | 15.8% | -3.2% | -31% | -127.2% |
| Net Income | $35,464 | -$25,028 | -$36,231 | -$44,215 |
| % Margin | 8% | -10.4% | -38.8% | -146.1% |
| EPS Diluted | 1.01 | -0.77 | -1.23 | -1.6 |
| % Growth | 231.2% | 37.4% | 23.1% | – |
| Operating Cash Flow | $48,803 | -$13,028 | -$45,817 | -$28,864 |
| Capital Expenditures | -$129,744 | -$179,059 | -$11,907 | -$3,519 |
| Free Cash Flow | -$80,941 | -$192,087 | -$57,724 | -$32,383 |